Limits...
Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction.

Moureau-Zabotto L, Teissier E, Cowen D, Azria D, Ellis S, Resbeut M - Gastroenterol Res Pract (2015)

Bottom Line: The 3-year ORR was 48%.Using univariate analysis ORR was significantly increased for patients with Siewert II/III compared to Siewert I tumors (27.3% versus 62%, p = 0.047).For OGJA treated with preoperative CRT and surgery, ORR and CRMR were lower for patients with Siewert I tumors in comparison with Siewert II/III tumors.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiation Therapy, Institut Paoli Calmettes, 232 boulevard de Sainte Marguerite, 13009 Marseille, France.

ABSTRACT
The aim of the study is to analyze the impact of the Siewert classification on the pathological complete response (pcR), pattern of failure, and general outcome of patients treated, by preoperative chemoradiotherapy and surgery for an gastroesophageal junction adenocarcinoma (OGJA). From 2000 to 2008, the charts of 68 patients were retrospectively reviewed. Tumor staging reported was UST1/T2/T3/T4/unknown, respectively, n = 1/7/54/5/1 patients, and N0/N1/unknown, respectively, n = 9/58/1 patients. Patients received primary external-beam radiotherapy with concurrent chemotherapy followed by surgical resection (Siewert I: upper oesogastrectomy; Siewert II/III: total gastrectomy with lower oesophagectomy). Overall survival (OS), overall relapse rate (ORR), cumulative rate of local (CRLR), nodal (CRNR), and metastatic (CRMR) relapse, and their prognostic factors were retrospectively analyzed. Median follow-up was 77.5 months. Median OS was 41.7 ± 5.2 months. The 3-year ORR was 48%. Using univariate analysis ORR was significantly increased for patients with Siewert II/III compared to Siewert I tumors (27.3% versus 62%, p = 0.047). Siewert I tumors had also statistically lower CRNR and CRMR compared to Siewert II/III tumors (0/9.1% versus 41.3/60.2% resp., p = 0.012), despite an equivalent cumulative rate of local relapse and pathological complete response rate between the three groups. For OGJA treated with preoperative CRT and surgery, ORR and CRMR were lower for patients with Siewert I tumors in comparison with Siewert II/III tumors.

No MeSH data available.


Related in: MedlinePlus

Cumulative rate of local recurrence (CRLR) (a), nodal recurrence (NRLR) (b), and metastatic recurrence (MRLR) (c) according to the Siewert classification (Siewert type 1 versus Siewert types 2 and 3).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4581544&req=5

fig3: Cumulative rate of local recurrence (CRLR) (a), nodal recurrence (NRLR) (b), and metastatic recurrence (MRLR) (c) according to the Siewert classification (Siewert type 1 versus Siewert types 2 and 3).

Mentions: ORR was statistically lower for Siewert 1 tumors in comparison to Siewert 2 and 3 tumors (p = 0.047, Figure 2). There was no statistical difference in terms of CRLR between the three Siewert groups; however, Siewert 1 tumors had statistically lower CRNR and CRMR in comparison to Siewert 2 and 3 tumors (Table 3, Figures 3(a), 3(b), and 3(c), resp.)


Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction.

Moureau-Zabotto L, Teissier E, Cowen D, Azria D, Ellis S, Resbeut M - Gastroenterol Res Pract (2015)

Cumulative rate of local recurrence (CRLR) (a), nodal recurrence (NRLR) (b), and metastatic recurrence (MRLR) (c) according to the Siewert classification (Siewert type 1 versus Siewert types 2 and 3).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4581544&req=5

fig3: Cumulative rate of local recurrence (CRLR) (a), nodal recurrence (NRLR) (b), and metastatic recurrence (MRLR) (c) according to the Siewert classification (Siewert type 1 versus Siewert types 2 and 3).
Mentions: ORR was statistically lower for Siewert 1 tumors in comparison to Siewert 2 and 3 tumors (p = 0.047, Figure 2). There was no statistical difference in terms of CRLR between the three Siewert groups; however, Siewert 1 tumors had statistically lower CRNR and CRMR in comparison to Siewert 2 and 3 tumors (Table 3, Figures 3(a), 3(b), and 3(c), resp.)

Bottom Line: The 3-year ORR was 48%.Using univariate analysis ORR was significantly increased for patients with Siewert II/III compared to Siewert I tumors (27.3% versus 62%, p = 0.047).For OGJA treated with preoperative CRT and surgery, ORR and CRMR were lower for patients with Siewert I tumors in comparison with Siewert II/III tumors.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiation Therapy, Institut Paoli Calmettes, 232 boulevard de Sainte Marguerite, 13009 Marseille, France.

ABSTRACT
The aim of the study is to analyze the impact of the Siewert classification on the pathological complete response (pcR), pattern of failure, and general outcome of patients treated, by preoperative chemoradiotherapy and surgery for an gastroesophageal junction adenocarcinoma (OGJA). From 2000 to 2008, the charts of 68 patients were retrospectively reviewed. Tumor staging reported was UST1/T2/T3/T4/unknown, respectively, n = 1/7/54/5/1 patients, and N0/N1/unknown, respectively, n = 9/58/1 patients. Patients received primary external-beam radiotherapy with concurrent chemotherapy followed by surgical resection (Siewert I: upper oesogastrectomy; Siewert II/III: total gastrectomy with lower oesophagectomy). Overall survival (OS), overall relapse rate (ORR), cumulative rate of local (CRLR), nodal (CRNR), and metastatic (CRMR) relapse, and their prognostic factors were retrospectively analyzed. Median follow-up was 77.5 months. Median OS was 41.7 ± 5.2 months. The 3-year ORR was 48%. Using univariate analysis ORR was significantly increased for patients with Siewert II/III compared to Siewert I tumors (27.3% versus 62%, p = 0.047). Siewert I tumors had also statistically lower CRNR and CRMR compared to Siewert II/III tumors (0/9.1% versus 41.3/60.2% resp., p = 0.012), despite an equivalent cumulative rate of local relapse and pathological complete response rate between the three groups. For OGJA treated with preoperative CRT and surgery, ORR and CRMR were lower for patients with Siewert I tumors in comparison with Siewert II/III tumors.

No MeSH data available.


Related in: MedlinePlus